Status:
COMPLETED
Evaluation of the Success of Prophylactic Enteral Nutrition in Therapeutic Intensification With Autograft of Autologous Hematopoietic Cells in Hematology
Lead Sponsor:
University Hospital, Bordeaux
Conditions:
Lymphoma
Myeloma
Eligibility:
All Genders
18+ years
Brief Summary
When the digestive tract is functional, learned societies recommend the use of a nutritional support by enteral feeding. Indeed, it has many advantages (maintenance of gut trophicity, reduction of the...
Detailed Description
In the literature, there are many studies on the nutritional support to be used during allografts, that highlight the superiority of enteral nutrition over parenteral nutrition in terms of reducing co...
Eligibility Criteria
Inclusion
- Patient with lymphoma or myeloma
- Patient admitted for therapeutic intensification with autologous hematopoietic cells who are eligible for nutritional support by enteral nutrition
- Free, informed and written consent signed by the patient
Exclusion
- Refusal of the enteral nutrition
- All patients with absolute or enteral nutrition contraindications:
- Digestive fistula
- Intestinal obstruction
- Intestinal ischemia
- Active digestive bleeding
- Digestive malabsorption (short hail syndrome, bariatric surgery, gastrectomy)
- Trauma to the base of the skull or significant deviation of the nasal septum not allowing the insertion of an naso gastric probe.
- Esophagitis or barrett's esophagus
- Persistent gastro-duodenal dysfunction (gastroparesis)
- Patients admitted for autograft for the treatment of conditions other than lymphoma or myeloma (e. g. solid tumours or leukaemia)
Key Trial Info
Start Date :
May 20 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 6 2023
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT04703985
Start Date
May 20 2021
End Date
November 6 2023
Last Update
December 7 2023
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
CH de la Côte Basque
Bayonne, France
2
CHU Bordeaux
Bordeaux, France